Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Jun;34(6):1112–1117. doi: 10.1128/aac.34.6.1112

Inhibitory effects of atropine, protamine, and their combination on hepatitis A virus replication in PLC/PRF/5 cells.

E Biziagos 1, J M Crance 1, J Passagot 1, R Deloince 1
PMCID: PMC171767  PMID: 2168143

Abstract

Atropine, protamine, and the combination of these drugs were tested for their effects on hepatitis A virus (HAV) replication in cell culture. PLC/PRF/5 hepatoma cells were treated simultaneously with nontoxic concentrations of these drugs and inoculated with HAV strain CF 53 at several multiplicities of infection. The yields of infectious HAV after 4 and 15 days were markedly reduced by each drug, especially at the lowest multiplicity of infection. The activities of each drug were irreversible. Atropine was active when it was added as late as 2 h after inoculation with HAV. An anti-HAV effect was also induced by treating cells with atropine prior to inoculation. Protamine was active as late as 6 h postinoculation. The combination of atropine and protamine resulted in an enhanced anti-HAV effect. We concluded that these drugs affect undetermined, but separate, steps in the HAV replication cycle.

Full text

PDF
1112

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón B., González M. E., Carrasco L. Antiherpesvirus action of atropine. Antimicrob Agents Chemother. 1984 Nov;26(5):702–706. doi: 10.1128/aac.26.5.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allen L. B., Vanderslice L. K., Fingal C. M., McCright F. H., Harris E. F., Cook P. D. Evaluation of the anti-herpesvirus drug combinations: virazole plus arabinofuranosylhypoxanthine and virazole plus arabinofuranosyladenine. Antiviral Res. 1982 Sep;2(4):203–216. doi: 10.1016/0166-3542(82)90043-2. [DOI] [PubMed] [Google Scholar]
  3. Anderson D. A., Ross B. C., Locarnini S. A. Restricted replication of hepatitis A virus in cell culture: encapsidation of viral RNA depletes the pool of RNA available for replication. J Virol. 1988 Nov;62(11):4201–4206. doi: 10.1128/jvi.62.11.4201-4206.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ayisi N. K., Gupta V. S., Meldrum J. B., Taneja A. K., Babiuk L. A. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with adenine arabinoside, 5-ethyldeoxyuridine, 5-iododeoxyuridine, and phosphonoacetic acid against herpes simplex virus types 1 and 2. Antimicrob Agents Chemother. 1980 Apr;17(4):558–566. doi: 10.1128/aac.17.4.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berenbaum M. C. A method for testing for synergy with any number of agents. J Infect Dis. 1978 Feb;137(2):122–130. doi: 10.1093/infdis/137.2.122. [DOI] [PubMed] [Google Scholar]
  6. Biziagos E., Crance J. M., Passagot J., Deloince R. Effect of antiviral substances on hepatitis A virus replication in vitro. J Med Virol. 1987 May;22(1):57–66. doi: 10.1002/jmv.1890220108. [DOI] [PubMed] [Google Scholar]
  7. Biziagos E., Passagot J., Crance J. M., Deloince R. Long-term survival of hepatitis A virus and poliovirus type 1 in mineral water. Appl Environ Microbiol. 1988 Nov;54(11):2705–2710. doi: 10.1128/aem.54.11.2705-2710.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. CURTIS D. R., PHILLIS J. W. The action of procaine and atropine on spinal neurones. J Physiol. 1960 Aug;153:17–34. doi: 10.1113/jphysiol.1960.sp006516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Crance J. M., Passagot J., Biziagos E., Deloince R. Continuous production of hepatitis A virus in PLC/PRF/5 cell cultures: use of antigen for serology. J Virol Methods. 1987 Nov;18(2-3):193–203. doi: 10.1016/0166-0934(87)90124-8. [DOI] [PubMed] [Google Scholar]
  10. Crance J. M., Passagot J., Verwaerde N., Biziagos E., Gandré H., Deloince R. Adaptation à la lignée cellulaire PLC/PRF/5 du virus de l'hépatite A libéré dans le surnageant de culture. C R Acad Sci III. 1985;301(7):361–363. [PubMed] [Google Scholar]
  11. Erecińska M., Nelson D., Silver I. A. Interactions of benztropine, atropine and ketamine with veratridine-activated sodium channels: effects on membrane depolarization, K+-efflux and neurotransmitter amino acid release. Br J Pharmacol. 1988 Jul;94(3):871–881. doi: 10.1111/j.1476-5381.1988.tb11599.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gaffey M. J., Gwaltney J. M., Jr, Dressler W. E., Sorrentino J. V., Hayden F. G. Intranasally administered atropine methonitrate treatment of experimental rhinovirus colds. Am Rev Respir Dis. 1987 Jan;135(1):241–244. doi: 10.1164/arrd.1987.135.1.241. [DOI] [PubMed] [Google Scholar]
  13. Hayden F. G., Douglas R. G., Jr, Simons R. Enhancement of activity against influenza viruses by combinations of antiviral agents. Antimicrob Agents Chemother. 1980 Oct;18(4):536–541. doi: 10.1128/aac.18.4.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jaques L. B. Protamine--antagonist to heparin. Can Med Assoc J. 1973 May 19;108(10):1291–1297. [PMC free article] [PubMed] [Google Scholar]
  15. Lemon S. M. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985 Oct 24;313(17):1059–1067. doi: 10.1056/NEJM198510243131706. [DOI] [PubMed] [Google Scholar]
  16. Rothschild A. M., Gomes E. L. Atropine and hexamethonium-sensitive, Ca/K-modulated, reversible swelling of mast cells in rat mesentery, due to feeding or exposure to carbachol. Agents Actions. 1988 Aug;25(1-2):4–10. doi: 10.1007/BF01969086. [DOI] [PubMed] [Google Scholar]
  17. Schinazi R. F., Peters J., Williams C. C., Chance D., Nahmias A. J. Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice. Antimicrob Agents Chemother. 1982 Sep;22(3):499–507. doi: 10.1128/aac.22.3.499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Siegl G., Eggers H. J. Failure of guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to inhibit replication of hepatitis A virus in vitro. J Gen Virol. 1982 Jul;61(Pt 50):111–114. doi: 10.1099/0022-1317-61-1-111. [DOI] [PubMed] [Google Scholar]
  19. Smith T. J., Kremer M. J., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M. G., McKinlay M. A., Diana G. D., Otto M. J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 1986 Sep 19;233(4770):1286–1293. doi: 10.1126/science.3018924. [DOI] [PubMed] [Google Scholar]
  20. Stenberg K., Wangenheim J., Tribukait B. Quantitative analysis of antiviral drug toxicity in proliferating cells. Cell Biol Toxicol. 1986 Dec;2(4):441–455. doi: 10.1007/BF00117847. [DOI] [PubMed] [Google Scholar]
  21. Superti F., Seganti L., Orsi N., Divizia M., Gabrieli R., Panà A. The effect of lipophilic amines on the growth of hepatitis A virus in Frp/3 cells. Arch Virol. 1987;96(3-4):289–296. doi: 10.1007/BF01320970. [DOI] [PubMed] [Google Scholar]
  22. Talib S., Banerjee A. K. Protamine--a potent inhibitor of vesicular stomatitis virus transcriptase in vitro. Biochem Biophys Res Commun. 1981 Feb 12;98(3):875–883. doi: 10.1016/0006-291x(81)91192-x. [DOI] [PubMed] [Google Scholar]
  23. Wheeler C. M., Fields H. A., Schable C. A., Meinke W. J., Maynard J. E. Adsorption, purification, and growth characteristics of hepatitis A virus strain HAS-15 propagated in fetal rhesus monkey kidney cells. J Clin Microbiol. 1986 Mar;23(3):434–440. doi: 10.1128/jcm.23.3.434-440.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Widell A., Hansson B. G., Moestrup T., Serléus Z., Mathiesen L. R., Johnsson T. Acute hepatitis A, B and non-A, non-B in a Swedish community studied over a ten-year period. Scand J Infect Dis. 1982;14(4):253–259. doi: 10.3109/inf.1982.14.issue-4.02. [DOI] [PubMed] [Google Scholar]
  25. Widell A., Hansson B. G., Oberg B., Nordenfelt E. Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus. Antiviral Res. 1986 Mar;6(2):103–112. doi: 10.1016/0166-3542(86)90030-6. [DOI] [PubMed] [Google Scholar]
  26. Yamazaki Z., Tagaya I. Antiviral effects of atropine and caffeine. J Gen Virol. 1980 Oct;50(2):429–431. doi: 10.1099/0022-1317-50-2-429. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES